Member Info for chrishutch

Amazed how many people can’t see the value in the current price. This is not a keep the lights on moment, this was clever and backed by strength.

I firmly believe we will see a bag or two in the coming months

Currently.

Time to buy in, average down, or take advantage. This is going to be worth more very soon.

See you when price is higher

I also started buying back in and will continue to do so

On sells, maybe an order being worked

I saw 250 a month too, but I can’t workout how it is so high, the cash from same broker not was 487k remaining end of sept which would imply they have run out of cash . However there was a comment in interview that’they were close to neural cash in cash out for at least one month.

So I guess it depends if the revenues in are continuing at that level or not.

there has been a real confusion over what is real and what is not. As the information in public domain is. Vague. If cash in is continuing to cover costs then obviously no need for. A cash injection, but it is a slightly risky operating model to be on the bread line, so to speak.

so do they try and continue with hope that bigger contracts will land and potential grant kicks in. Or do they take an injection of cash and have a much bigger safety net.

Who knows

Today

Https://x.com/dds_docholiday/status/1734563149100015826?s=61

Through 1 this time

We are going up

Easy bagger from down here

Wow that is one of the most positive and bullish interviews I have heard for a long long time. To have a CEO sound so happy and use words like buzzing, absolutely delighted, best we could have hoped, major news, looking forward and good for mankind and animal kind.

Well done Adrian and congratulations on the start of what I believe will be a #fab future.

Morning all hopefully a nice bounce roday

:-)

Be nice to go red to blue

Reflecting on our recent announcement, our CEO Adrian Kinkaid has made the following comments:

"I am delighted to have the agreement to work with NCI, one of the best possible partners at this stage of development.

Three of the key benefits of OptiMAL® in the discovery of novel antibodies are highly significant. The platform enables screening with:

1. fully intact IgG antibodies (rather than fragments which have to be stitched together often to the detriment of binding efficacy)

2. antibodies expressed in a mammalian cell (the preferred system for production of therapeutic antibodies)

3. a highly diverse library of sequences based on Fusion's proprietary design methods using the human immune repertoire

All of these are entirely consistent with the Fusion philosophy to 'begin with the end in mind'.

Any one wanting further information on this ground breaking antibody discovery platform should contact Fusion: info@fusionantibodies.com , or myself."

And more

And some more

Just the 15k so fa, buying some of my trading ones back

Be interesting to see if it bounces or we wait for news